Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 2901-2920 of 3,190 trials

Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma.

NCT01939951

This study aims to find out if AES ( Activation Energy Serum) , a blend of natural minerals , is effective and safe for the treatment of asthma if taken for 4 weeks . The efficacy will be scientifically tested by symptoms scores, questionnaires, breathing and blood tests.

Mild to Moderate Persistent Asthma

California Allergy and Asthma Medical Group, Inc.60 participantsStarted Jan 2014

Los Angeles, California, United States

COMPLETEDPhase 2< 1 mile

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

NCT00003203

RATIONALE: Drugs used in chemotherapy, such as carboplatin and vincristine, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining carboplatin and vincristine with radiation therapy followed by adjuvant chemotherapy may kill more tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of combination chemotherapy plus radiation therapy followed adjuvant chemotherapy in treating young patients who have newly diagnosed high-risk CNS embryonal tumors.

Brain TumorsCentral Nervous System TumorsNeuroblastoma

Children's Oncology Group168 participantsStarted Mar 1998

Long Beach, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +35 more locations

Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma.

Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

Rheumatoid Arthritis Trials in Other Cities

Lobradimil and Carboplatin in Treating Children With Brain Tumors

Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001

A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

Kineflex Artificial Disc System to Treat Degenerative Disc Disease (DDD)

Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor

Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas

RESTART C0168Z05 Rheumatoid Arthritis Study

An Open Label Extension Study in Subjects With Fragile X Syndrome

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Shingles Prevention Study

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study

Other Conditions in Los Angeles